Dennis ÅsbergResearch Scientist, Analysis & Separation at Novo Nordisk A/S
Dennis Åsberg is working as a Research Scientist in Global Research Technologies, at Novo Nordisk. He is developing analysis methods in the drug discovery phase for peptide and protein therapeutics and is coordinating transfer of analytical methods to CMC. He received his PhD from Karlstad University, Sweden, working with the analysis of small molecules in collaboration with AstraZeneca R&D, Gothenburg. The focus was on the incorporation of Quality by Design in regulated area to enable continuous improvements and life-cycle management of analytical methods.